Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)

Sensus Healthcare has reported Cash from Financing Activities over the past 9 years, most recently at -$5000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0; the TTM value through Dec 2025 reached -$305000.0, down 535.42%, while the annual FY2025 figure was -$305000.0, 2133.33% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$5000.0 at Sensus Healthcare, up from -$300000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $273000.0 in Q1 2022 and troughed at -$1.9 million in Q4 2022.
  • A 5-year average of -$200400.0 and a median of -$39000.0 in 2023 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 555.0% in 2022 and fell as far as 3481.48% in 2022.
  • Year by year, Cash from Financing Activities stood at -$54000.0 in 2021, then tumbled by 3481.48% to -$1.9 million in 2022, then skyrocketed by 99.64% to -$7000.0 in 2023, then soared by 500.0% to $28000.0 in 2024, then plummeted by 117.86% to -$5000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SRTS at -$5000.0 in Q4 2025, -$300000.0 in Q1 2025, and $28000.0 in Q4 2024.